Chagas disease program (DNDi/Epichem/Monash University/Griffiths University/London School of Hygiene and Tropical Medicine/WuXi AppTech/University of Campinas/AbbVie/Sanofi/University of Antwerp/TCG Life Sciences)

N/A

Report date: 2025/06/11 10:30:32

NME

Base Information

Drug NameChagas disease program (DNDi/Epichem/Monash University/Griffiths University/London School of Hygiene and Tropical Medicine/WuXi AppTech/University of Campinas/AbbVie/Sanofi/University of Antwerp/TCG Life Sciences)

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsChagas Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesDrugs For Neglected Diseases Initiative

China Registration ClassN/A

Develop Information

Active CompaniesEpichem Group Ltd Centre for Drug Candidate Optimisation Griffith University +[12]

Inactive CompaniesN/A

Active IndicationsChagas Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A